REAL-WORLD COSTS IN BIOLOGIC NAIVE PSORIATIC ARTHRITIS PATIENTS INITIATING APREMILAST OR BIOLOGICS IN A US HEALTHCARE CLAIMS DATABASE

被引：0
|
作者：
Kaplan, D. [1 ]
Ung, B. [2 ]
Udeze, C. [3 ]
Pelletier, C. [3 ]
Tian, M. [3 ]
机构：
[1] Adult & Pediat Dermatol, Overland Pk, KS USA
[2] Celgene Corp, Morris Plains, NJ USA
[3] Celgene Corp, Summit, NJ USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS15
引用
收藏
页码：S888 / S888
页数：1
相关论文
共 50 条
  • [31] PREVALENCE, REAL-WORLD HEALTHCARE RESOURCE UTILIZATION, AND COSTS OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE US: A RETROSPECTIVE CLAIMS DATABASE ANALYSIS
    Tantravahi, S.
    Latremouille-Viau, D.
    Desai, R.
    Lee, S.
    Paulose, J.
    Geevarghese, A.
    Guerin, A.
    Seshasayee, S.
    Tabatabaeepour, N.
    Chanpura, M.
    Yen, G.
    VALUE IN HEALTH, 2024, 27 (06) : S140 - S140
  • [32] REAL-WORLD EVALUATION OF TNF INHIBITOR UTILISATION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN A US CLAIMS DATABASE
    Harnett, J.
    Wiederkehr, D.
    Gerber, R.
    Gruben, D.
    Koenig, A.
    Bourret, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 229 - 229
  • [33] Early Treatment Failure with Apremilast Among Biologic-naive Patients with Psoriatic Arthritis
    Betts, Keith
    Patel, Pankaj
    Song, Jinlin
    Zhao, Jing
    Wang, Yan
    Griffith, Jenny
    Wu, Eric
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] Real-World Treatment Patterns and Healthcare Costs in Patients with Psoriatic Arthritis Treated with Ixekizumab: A Retrospective Study
    Murage, Mwangi J.
    Princic, Nicole
    Park, Julie
    Malatestinic, William
    Zhu, Baojin
    Atiya, Bilal
    Kern, Scott A.
    Stenger, Keri B.
    Sprabery, Aubrey Trevelin
    Ogdie, Alexis
    ACR OPEN RHEUMATOLOGY, 2021, 3 (12) : 879 - 887
  • [35] PERSISTENCE WITH SUBCUTANEOUSLY ADMINISTERED BIOLOGICS AMONG PATIENTS WITH PSORIATIC ARTHRITIS: ANALYSES FROM A US CLAIMS DATABASE
    Oelke, K.
    Chambenoit, O.
    Majjhoo, A.
    Gray, S.
    Higgins, K.
    Hur, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1591 - 1591
  • [36] Real-World Experience with Tofacitinib Versus Adalimumab and Etanercept in Biologic-Naive Patients with RA Previously Treated with Methotrexate: Data from a US Administrative Healthcare Insurance Claims Database
    Smith, Tim
    Harnett, James
    Gruben, David
    Chen, Connie
    Agarwal, Ekta
    Woolcott, John
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [37] Rates of Treated Depression Among Patients with Psoriatic Arthritis Treated with Apremilast, Biologics, DMARDs, and Corticosteroids in the US MarketScan Database
    Vasilakis-Scaramozza, Catherine
    Persson, Rebecca
    Hagberg, Katrina Wilcox
    Niemcryk, Steve
    Peng, Michael
    Paris, Maria
    Lindholm, Anders
    Jick, Susan
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [38] REAL-WORLD STUDY ON THE PATTERNS AND COST OF TREATMENT FAILURE IN PATIENTS WITH PSORIATIC ARTHRITIS USING US CLAIMS DATA
    Price, K.
    Alemao, E.
    Burns, L.
    Guo, Z.
    Anupindi, V.
    Goday, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 677 - 677
  • [39] Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database
    Hur, Peter
    Kim, Nina
    Dai, Dong
    Piao, Olivia W.
    Zheng, Josh Z.
    Yi, Esther
    DRUGS-REAL WORLD OUTCOMES, 2021, 8 (01) : 29 - 38
  • [40] Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database
    Peter Hur
    Nina Kim
    Dong Dai
    Olivia W. Piao
    Josh Z. Zheng
    Esther Yi
    Drugs - Real World Outcomes, 2021, 8 : 29 - 38
12345